These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 17641893

  • 1. Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.
    Masuda N, Taguchi T, Nakayama T, Shiba E, Watatani M, Kurebayashi J, Takatsuka Y, Sakamoto J, Noguchi S, Kinki Breast Cancer Study Group (KBCSG).
    Cancer Chemother Pharmacol; 2008 May; 61(6):989-95. PubMed ID: 17641893
    [Abstract] [Full Text] [Related]

  • 2. Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.
    Uhlmann C, Ballabeni P, Rijken N, Brauchli P, Mingrone W, Rauch D, Pestalozzi BC, Rochlitz C, Aebi S, Swiss Group for Clinical Cancer Research, Swiss Institute for Applied Cancer Research.
    Oncology; 2004 May; 67(2):117-22. PubMed ID: 15539915
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 4. Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
    Blum JL, Dees EC, Chacko A, Doane L, Ethirajan S, Hopkins J, McMahon R, Merten S, Negron A, Neubauer M, Ilegbodu D, Boehm KA, Asmar L, O'Shaughnessy JA.
    J Clin Oncol; 2006 Sep 20; 24(27):4384-90. PubMed ID: 16926223
    [Abstract] [Full Text] [Related]

  • 5. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
    O'connor T, Rustum Y, Levine E, Creaven P.
    Cancer Chemother Pharmacol; 2008 Jan 20; 61(1):125-31. PubMed ID: 17426973
    [Abstract] [Full Text] [Related]

  • 6. Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer.
    Susnjar S, Bosnjak S, Radulovic S, Stevanovic J, Gajic-Dobrosavljevic M, Kreacic M.
    J BUON; 2007 Jan 20; 12(2):189-96. PubMed ID: 17600871
    [Abstract] [Full Text] [Related]

  • 7. Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609.
    Taguchi T, Yamamoto D, Masuda N, Oba K, Nakayama T, Nagata T, Nomura M, Yoshidome K, Yoshino H, Matsunami N, Miyashita M, Furuya Y, Ishida T, Wakita K, Sakamoto J, Noguchi S, Kinki Breast Cancer Study Group (KBCSG).
    Cancer Chemother Pharmacol; 2013 Mar 20; 71(3):741-7. PubMed ID: 23334260
    [Abstract] [Full Text] [Related]

  • 8. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.
    Sym SJ, Ryu MH, Kang HJ, Lee SS, Chang HM, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK.
    Cancer Chemother Pharmacol; 2010 Jul 20; 66(2):373-80. PubMed ID: 19936751
    [Abstract] [Full Text] [Related]

  • 9. [A phase I study of combination therapy with capecitabine and paclitaxel for patients with inoperable breast cancer or recurrent breast cancer].
    Horiguchi J, Koibuchi Y, Rokutanda N, Nagaoka R, Kikuchi M, Sato A, Odawara H, Ishikawa Y, Tokiniwa H, Iino Y, Takeyoshi I.
    Gan To Kagaku Ryoho; 2008 Nov 20; 35(11):1877-81. PubMed ID: 19011335
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group.
    Lück HJ, Du Bois A, Loibl S, Schrader I, Huober J, Heilmann V, Beckmann M, Stähler A, Jackisch C, Hubalek M, Richter B, Stickeler E, Eidtmann H, Thomssen C, Untch M, Wollschläger K, Schuster T, von Minckwitz G.
    Breast Cancer Res Treat; 2013 Jun 20; 139(3):779-87. PubMed ID: 23771714
    [Abstract] [Full Text] [Related]

  • 12. A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
    Campone M, Isambert N, Bourbouloux E, Roché H, Bonneterre J, Milano G, Fumoleau P.
    Cancer Chemother Pharmacol; 2012 Apr 20; 69(4):871-9. PubMed ID: 22045498
    [Abstract] [Full Text] [Related]

  • 13. A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma.
    Czito BG, Kelsey CR, Hurwitz HI, Willett CG, Morse MA, Blobe GC, Fernando NH, D'Amico TA, Harpole DH, Honeycutt W, Yu D, Bendell JC.
    Int J Radiat Oncol Biol Phys; 2007 Mar 15; 67(4):1002-7. PubMed ID: 17197129
    [Abstract] [Full Text] [Related]

  • 14. Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer.
    Schwartzberg LS, Arena FP, Mintzer DM, Epperson AL, Walker MS.
    Clin Breast Cancer; 2012 Apr 15; 12(2):87-93. PubMed ID: 22154117
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
    Blum JL, Dees EC, Vukelja SJ, Amare M, Gill DP, McMahon RT, Ilegbodu D, Asmar L, O'Shaughnessy JA.
    Clin Breast Cancer; 2007 Feb 15; 7(6):465-70. PubMed ID: 17386123
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.
    Gick U, Rochlitz C, Mingrone W, Pestalozzi B, Rauch D, Ballabeni P, Lanz D, Hess V, Aebi S.
    Oncology; 2006 Feb 15; 71(1-2):54-60. PubMed ID: 17344671
    [Abstract] [Full Text] [Related]

  • 18. Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer.
    Chitapanarux I, Kamnerdsupaphon P, Tharavichitkul E, Lorvidhaya V, Trakultivakorn H, Srisukho S, Somwangprasert A, Watcharachan K, Sukthomya V.
    Asia Pac J Clin Oncol; 2012 Mar 15; 8(1):76-82. PubMed ID: 22369447
    [Abstract] [Full Text] [Related]

  • 19. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D, Frassineti GL, Zoli W, Milandri C, Tienghi A, Ravaioli A, Gentile A, Salzano E.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies.
    Saif MW, Lansigan F, Ruta S, Lamb L, Mezes M, Elligers K, Grant N, Jiang ZL, Liu SH, Cheng YC.
    Phytomedicine; 2010 Mar 15; 17(3-4):161-9. PubMed ID: 20092990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.